Iproclozide

Iproclozide Overview

Iproclozide is a historical psychotropic medication that was previously utilized within the Psychiatry department for the management of clinical depression. Chemically, this compound belongs to the class of organic compounds known as phenol ethers, which are aromatic compounds containing an ether group substituted with a benzene ring. Functioning as an irreversible and selective monoamine oxidase inhibitor (MAOI) of the hydrazine class, Iproclozide was employed as an effective antidepressant for a brief period. However, its clinical lifespan was cut short after it was discovered that the agent was capable of causing fulminant hepatitis. Following documented reports of at least three fatalities directly linked to this severe liver toxicity, Iproclozide was globally discontinued.

What Is Iproclozide & How Does It Work?

Iproclozide is a small molecule psychoanaleptic that functions biologically as an irreversible monoamine oxidase inhibitor (MAOI). While specific modern pharmacological data regarding its exact binding affinities are currently listed as not available, drugs within the hydrazine MAOI class generally operate by permanently binding to monoamine oxidase enzymes in the central nervous system.

By irreversibly inhibiting these critical enzymes, Iproclozide prevented the metabolic breakdown of essential biogenic amines, including serotonin, norepinephrine, and dopamine. This prolonged enzymatic blockade led to a significant accumulation of these neurotransmitters within the synaptic cleft. The resulting enhancement of neural signaling elevated mood, increased energy levels, and alleviated the pervasive symptoms of severe depressive disorders before the drug’s profound toxicity profile was fully understood.

Is Iproclozide FDA Approved?

Iproclozide is not approved by the United States Food and Drug Administration (FDA) for clinical prescription in the United States. Although it was utilized internationally as an antidepressant under brand names such as Sinderesin and Sursum, it was ultimately withdrawn from all global markets. Because of its direct association with fatal fulminant hepatitis, it remains an unapproved and discontinued therapeutic agent.

What Is Iproclozide Used For?

• The historical symptomatic treatment and clinical management of severe clinical depression.
• Utilized historically as a potent psychoactive agent to elevate monoamine neurotransmitter levels in adult patients suffering from unremitting depressive disorders prior to its withdrawal.
• Currently, it serves no approved clinical purpose and is exclusively a compound of historical and toxicological interest.

Before Taking Iproclozide: Contraindications & Precautions

Because Iproclozide is an irreversible MAOI that carries a documented risk of fatal liver damage, extreme clinical caution, stringent dietary restrictions, and extensive drug screening would be absolutely mandatory. Today, its use is universally contraindicated.

Who Should Not Take Iproclozide?

• Patients with any pre-existing hepatic impairment, active liver disease, or elevated liver enzymes, as the drug is a known cause of fatal fulminant hepatitis.
• Individuals with a known severe allergy or hypersensitivity to Iproclozide, phenol ethers, or other hydrazine-class MAOIs.
• Patients with a history of cardiovascular disease, uncontrolled hypertension, or cerebrovascular defects, due to the standard MAOI risk of severe hypertensive crises.
• Patients currently taking other serotonergic drugs, central nervous system depressants, or sympathomimetic agents.

Iproclozide: Pregnancy & Fertility

• The safety of Iproclozide during human pregnancy was never established through modern, controlled clinical trials.
• Pregnant women were historically advised against using MAOIs unless absolutely necessary, as these agents can cause severe maternal hypertensive crises and severely compromise fetal blood flow.
• Nursing mothers were historically cautioned against its use, as toxic psychoactive compounds and MAOIs can be excreted into human breast milk, posing extreme risks to the nursing infant.

Tell Your Doctor Before Taking Iproclozide

• Disclose any personal or family history of liver disease, hepatitis, or abnormal liver function tests.
• Inform your doctor if you consume high amounts of tyramine-rich foods, as this is strictly contraindicated with any MAOI therapy.
• List all other medications, specifically highlighting other antidepressants, cold medicines, or weight-loss supplements, to avoid severe, lethal drug-to-drug interactions.

Iproclozide: Dosage & Administration

As an unapproved and discontinued medication that is no longer marketed anywhere in the world, standardized domestic dosing guidelines, specific dosage forms, and routes of administration for Iproclozide are currently listed as not available in modern pharmacological databases.

Standard Iproclozide Dosing

• When it was prescribed historically, dosing for hydrazine MAOIs like Iproclozide was highly individualized and required careful titration by a specialized psychiatrist to balance antidepressant efficacy against autonomic and hepatic side effects.
• In modern medicine, it is not prescribed in standard clinical practice, and its therapeutic dosing regimens are entirely obsolete.

How Iproclozide Is Administered

• Specific formulation and route details are not currently available for Iproclozide, though historical MAOIs of this era were universally administered as oral tablets or capsules.

Iproclozide: Clinical Efficacy & Research

During its brief period of clinical employment, Iproclozide proved to be an effective antidepressant. By acting as an irreversible MAOI, it successfully elevated monoamine neurotransmitter levels to combat severe depressive symptoms. However, its clinical efficacy was rapidly overshadowed by its catastrophic safety profile. Pharmacovigilance efforts quickly identified that Iproclozide was capable of causing fulminant hepatitis a rapid and severe failure of liver function. After its use was officially documented as the cause of at least three patient fatalities, the therapeutic window was deemed unacceptable, leading to the drug’s permanent discontinuation.

Iproclozide: Side Effects & Safety Profile

The safety profile of Iproclozide is dominated by the severe, life-threatening risks associated with acute hepatic failure and irreversible monoamine oxidase inhibition. Patients exposed to this compound were highly vulnerable to both organ failure and neurological emergencies.

Common Iproclozide Side Effects

• Orthostatic hypotension (severe dizziness or lightheadedness upon standing up quickly).
• Anticholinergic-like effects, such as a persistently dry mouth, blurred vision, and mild to moderate constipation.
• Central nervous system depression resulting in daytime drowsiness, fatigue, or generalized lethargy.

Serious Iproclozide Adverse Events

• Fulminant hepatitis, leading to acute liver failure, jaundice, and potential death.
• Severe, potentially fatal hypertensive crises, especially if the drug is consumed concurrently with tyramine-rich foods.
• Serotonin syndrome, characterized by severe agitation, hallucinations, hyperthermia (extreme fever), and a rapid, irregular heart rate.

Managing Iproclozide Side Effects

If signs of acute liver injury occurred such as sudden yellowing of the skin or eyes (jaundice), severe right-sided abdominal pain, or dark urine the drug was immediately discontinued and emergency hepatic support was initiated. If signs of a hypertensive crisis or serotonin syndrome emerged, immediate hospitalization was required for intensive cardiovascular and neurological supportive care.

Iproclozide: Interactions & What to Avoid

Iproclozide interacted profoundly and dangerously with a vast array of medications and dietary components, particularly those affecting serotonin pathways, vascular tone, and hepatic metabolism.

Iproclozide: Interactions

• Co-administration with other serotonergic drugs (like SSRIs, SNRIs, tricyclics, or other MAOIs) significantly increases the risk of life-threatening Serotonin Syndrome.
• Combining Iproclozide with central nervous system depressants can cause severe, additive respiratory and cognitive depression.
• Concomitant use with sympathomimetic agents (such as pseudoephedrine found in over-the-counter cold medicines) can trigger uncontrollable, lethal spikes in blood pressure.

Iproclozide: Food & Alcohol

• Strict dietary restrictions are an absolute requirement for MAOIs like Iproclozide. Patients must completely avoid tyramine-rich foods (such as aged cheeses, cured meats, fermented soy products, and tap beer) to prevent fatal hypertensive crises.
• Alcohol consumption must be strictly avoided. Many alcoholic beverages contain high levels of tyramine, and alcohol itself dangerously amplifies the central nervous system depression and hepatic strain associated with the drug.

Iproclozide: Missed Dose, Overdose & Storage

Because the drug is no longer used in standard clinical practice, daily patient dosing schedules do not currently apply.

Missed Dose of Iproclozide

Historically, if a dose of Iproclozide was missed, patients were advised to take it as soon as remembered unless it was nearly time for the next scheduled dose. They were strictly warned to avoid taking double doses to prevent sudden, overwhelming hepatic toxicity or autonomic crises.

Iproclozide: Overdose & Emergency

An overdose of a hydrazine MAOI like Iproclozide is a catastrophic medical emergency. Symptoms of toxicity rapidly progress to profound central nervous system depression, extreme tachycardia, hyperpyrexia (severe, dangerous fever), continuous convulsions, coma, and acute liver failure. Emergency medical treatment focuses on immediate intensive cardiovascular monitoring, gastric decontamination, and robust supportive care to manage hyperthermia, seizures, and organ failure.

How to Store Iproclozide

If retained for toxicological or historical research, Iproclozide compounds must be stored in highly controlled laboratory environments at room temperature, protected from excessive light and moisture, and kept strictly out of the reach of unauthorized personnel.

Iproclozide: Patient Management & Monitoring

When it was used clinically, psychiatric treatment with an irreversible MAOI required extreme vigilance regarding both liver health and dietary compliance.

Tests Before Starting Iproclozide

• Comprehensive baseline liver function tests (LFTs) to completely rule out pre-existing hepatic impairment.
• A baseline cardiovascular evaluation, checking resting blood pressure to rule out severe hypertension.

Monitoring During Iproclozide Treatment

• Routine, strict monitoring of liver enzymes (ALT, AST, bilirubin) during clinical visits to detect any early signs of drug-induced hepatitis.
• Continuous psychiatric evaluation to assess the reduction of depressive symptoms and ensure total, unwavering adherence to MAOI dietary restrictions.

Iproclozide: Do’s and Don’ts

• Do strictly adhere to a low-tyramine diet if you are ever exposed to an MAOI in a medical setting.
• Do not attempt to source or use Iproclozide for personal psychiatric treatment, as it is an unapproved, unmarketed, and highly lethal medication.
• Do not consume alcohol, aged cheeses, or cured meats while undergoing any form of MAOI therapy.
• Do not mix this compound with other antidepressants, asthma inhalers, or over-the-counter cold and allergy medicines.

Frequently Asked Questions

References

• DrugBank Database – Iproclozide Clinical and Pharmacological Profile
• Classyfire Database – Phenol Ethers Chemical Taxonomy Profile

Legal Disclaimer

The information provided is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider at any hospital or any local clinic before starting or stopping any medication.